Alyeska Investment Group
FUSN

Alyeska Investment Group’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Alyeska Investment Group’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-75,000
Closed -$606K – 826
2021
Q2 		$606K Hold
75,000
– – 0.01% 633
2021
Q1 		$804K Hold
75,000
– – 0.01% 617
2020
Q4 		$881K Sell
75,000
-600
-0.8% -$7.54K 0.01% 423
2020
Q3 		$909K Hold
75,600
– – 0.01% 395
2020
Q2 		$1.32M Buy
+75,600
New +$1.32M 0.02% 387

Other funds holding FUSN

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Alyeska Investment Group's FUSN Position: Q3 2021 in Review

Alyeska Investment Group sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q3 2021, closing a stake of 75,000 shares — an estimated $606K sold.

Alyeska Investment Group first reported a position in FUSN in Q2 2020 and held it in 5 quarters. The position peaked at $1.32M in Q2 2020. 40 funds tracked by Wall St. Rank hold FUSN as of Q3 2021.

  • Alyeska Investment Group reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 75,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q3 2021, an estimated $606K.
  • Alyeska Investment Group first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 5 quarters.
  • Alyeska Investment Group's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.32M in Q2 2020.
  • 40 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.